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In vitro experiments 
Preanalytical error 
A B S T R A C T   
Background: In vitro, the complement system can be studied in test tubes incubated with anticoagulated human 
whole-blood. Background activation of complement may mask inflammatory signals. Air bubbles are known to 
activate complement. We examined if removing ambient air from test tubes before incubation reduced back-
ground complement activation. 
Methods: Blood from twelve donors was anticoagulated with the thrombin inhibitor lepirudin and incubated 
with either no air, ambient air or air bubbles in polypropylene tubes at 37 °C for 180 min on a roller mixer. After 
incubation, EDTA was added, plasma isolated and analyzed for seven complement activation products using 
ELISA. Results are presented as means with 95% confidence intervals. 
Results: Blood incubated without air had significantly lower complement activation compared to blood in-
cubated with ambient air; C4d 273 (192–364) vs. 379 (263–494) ng/mL (p = 0.002), C4bc 8.2 (4.1–13) vs. 12 
(3.2–21) CAU/mL (p = 0.01), C3a 1351 (873–1838) vs. 2944 (2315–3572) ng/mL (p = 0.0005), C3bc 31 
(17–46) vs. 68 (52–84) CAU/mL (p = 0.002), C3bBbP 134 (97–171) vs. 427 (358–506) CAU/mL (p  <  0.0001), 
C5a 3.5 (1.9–5 0.2) vs. 15 (1.8–27)) ng/mL (p = 0.003), TCC 4.6 (2.8–6.3) vs. 9.9 (7.3–12) CAU/mL 
(p = 0.006). At the end of the experiment blood incubated with air bubbles had a higher complement activation 
than blood incubated with ambient air with an average 26 fold increase (range 1.6–59) from baseline of all 
activation products; C4d 551 (337–766) ng/mL, C4bc 21 (5.0–36) CAU/mL, C3a 3983 (3518–4448) ng/mL, 
C4bc 103 (86–121) CAU/mL, C3bBbP 626 (543–708) CAU/mL, C5a 10 (2.8–18) ng/mL and TCC 10 (6.0–14) 
CAU/mL. 
Conclusion: Avoiding air in test tubes during whole-blood experiments reduced background complement acti-
vation substantially and represents an important improvement to the lepirudin whole-blood model. This could 
also apply to other in vitro models.   
1. Introduction 
In 2002 we published a unique whole-blood model to study the role 
of complement in the inflammatory response in a holistic manner 
(Mollnes et al. 2002). This was made possible by anticoagulating the 
blood with the thrombin-specific inhibitor lepirudin, which does not 
interfere with the complement system when collecting blood for in vitro 
experiments. Undesired background activation of complement and 
other systems of inflammation in experimental whole-blood models is a 
common problem during in vitro studies (Lappegård et al. 2004), po-
tentially masking biologically relevant signals in the experiments. In 
1980, Track and colleagues discovered that the C3 molecule contained 
an internal thioester bond. This esther was continuously hydrolyzed at a 
low degree in the fluid phase and obtained a similar structure to C3b, 
but C3a was not cleaved off (Tack et al. 1980). This molecule was 
named iC3b, “C3b-like C3” and C3(H2O). The C3 hydrolysis concept has 
recently been reviewed (Fromell et al. 2020) and the role of C3(H2O) is 
still under debate. Blood-gas interfaces, such as found on air bubbles in 
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blood, have been shown to activate the complement system in vitro by 
the thioesther hydrolysis of C3 to C3(H2O). Interestingly, this hydro-
lyzation is independent of what type of gas the blood interfaces with, 
e.g. oxygen and nitrogen have similar effects on the complement system 
(Ekdahl et al. 1992). 
Despite knowledge of this C3 hydrolyzation, it is common labora-
tory practice to accept the presence of ambient air in test tubes during 
in vitro experiments. To our knowledge, the effect of ambient air inside 
test tubes on the complement system during incubations has not pre-
viously been examined. 
Thus, we studied if eliminating ambient air from test tubes during 
whole-blood experiments would reduce unwanted background activa-
tion of complement. Additionally, we examined if increasing the blood- 
air interface area by incubation with air bubbles would increase com-
plement activation. 
2. Material and methods 
Sixty 5 mL polypropylene Nunc 5 mL test tubes (Nalgene, Roskilde, 
DK) were prefilled with 80 μL lepirudin 2.5 mg/mL (Thermo Fisher 
Scientific, Roskilde, DK) and preserved at −20 °C. A vacuum of 
−19 mL air was applied to rethawed tubes using a syringe and a 23 G 
needle (Becton Dickinson, Franklin Lakes, NJ). Blood from twelve 
healthy human donors (five woman and seven men) aged between 40- 
and 50-years was drawn using a BD Vacutainer Eclipse blood collection 
needle (Becton Dickinson) into three lepirudin filled Nunc test tubes per 
donor, giving a final blood lepirudin concentration of 50 μg/mL. Blood 
from each donor was subsequently transferred to a 50 mL poly-
propylene conical Falcon tube (Corning, Tamaulipas, Mexico) pre-
heated to 37 °C. The blood samples “Baseline”, “Ambient air” and “Air 
bubbles” were prepared in the following way: On a block heater set to 
37 °C, 858 μL blood and 142 μL PBS with Ca2+ and Mg2+ was trans-
ferred to three polypropylene 1.8 mL Nunc tubes. To the baseline 
sample 14.6 μL EDTA was added immediately to block further com-
plement activation, and the tube kept on ice. The “No air” sample was 
prepared as follows: In a 5 mL Nunc tube 3 mL blood and 497 μL PBS 
with Ca2+ and Mg2+ was mixed and from here transferred to a 1.8 mL 
Nunc tube filling the tube and the tube lid completely. The tube was 
then carefully capped, ensuring no air was present inside (Fig. 1A). In 
the “Baseline” and “Ambient air” samples, approximately 3 mL ambient 
air was left between blood and tube cap (Fig. 1B). To the “Air bubbles” 
sample, ambient air was bubbled through the blood using a syringe and 
needle, resulting in a mixture of air bubbles and blood filling the tube 
completely (Fig. 1C). 
All tubes were capped and incubated on a Rock'n'Roller tube roller 
mixer (Labinco, Breda, NL) at 37 °C for 180 min. After incubation, 1 mL 
blood was transferred from the “No Air” tube to a new 1.8 mL Nunc 
tube. To this tube and the two other incubated tubes, 14.6 μL EDTA was 
added for a final concentration of 10 mM to block further complement 
activation. The samples were centrifuged at 3000g for 20 min at 4 °C, 
plasma transferred to polypropylene matrix tubes and frozen at −80 °C 
and later thawed for analysis of C3a, C3bc, C5a and TCC. Additionally, 
C4d, C4bc and C3bBbP was also analyzed in plasma from six of the 
donors. 
Commercial ELISA kits were used for C4d (C4d fragment, Quidel 
Corp., Athens, OH), C3a (MicroVue C3a Plus EIA, Quidel) and C5a (C5a 
Human ELISA kit, HyCult Biotech, Uden, The Netherlands). In-house 
developed ELISA assays was performed as previously described 
(Bergseth et al. 2013) and were used for analysis of C4bc, C3bBbP, C3bc 
and TCC. ELISA plates were read using a Tecan Infinite M200 plate 
scanner (Tecan Group, Männedorf, Switzerland) and the Magellan 7.1 
SP1 software (Tecan Group). 
2.1. Statistics 
Results were extracted and fold change between groups were cal-
culated using Microsoft Excel for Mac ver. 16.16.9 (Microsoft Inc., 
Redmond, CA). Statistical analysis and charting of results were done 
using Prism for Mac ver. 8.4.2 (Graphpad Software, La Jolla, CA). 
Missing baseline readouts due to lack of sample material were 
substituted with a random number between the lowest and the highest 
baseline result in the series. All results were stated as means with 95% 
confidence interval. As results did not follow a Gaussian distribution, 
data were log-transformed, and groups compared using the repeated 
measures ANOVA with Geisser-Greenhouse correction. Significances 
were calculated using the Fischer's LSD test. p  <  0.05 was considered 
significant. 
3. Results 
After 180 min of incubation, all complement activation products 
were increased in all samples, except for C4d in blood incubated 
without air (Table 1 and Fig. 2). The average level of complement ac-
tivation products were significantly lower in blood incubated without 
ambient air in the tubes compared to blood incubated with ambient air 
in tubes: C4d 273 (192–364) vs. 379 (263–494) ng/mL (p = 0.002), 
C4bc 8.2 (4.1–13) vs. 12 (3.2–21) CAU/mL (p = 0.01), C3a 1351 
(873–1838) vs. 2944 (2315–3572) ng/mL (p = 0.0005), C3bc 31 
(17–46) vs. 68 (52–84) CAU/mL (p = 0.002), C3bBbP 134 (97–171) vs. 
427 (358–506) CAU/mL (p  <  0.0001), C5a 3.5 (1.9–5.2) vs. 15 
Fig. 1. Blood was incubated in 1.8 mL polypropylene tubes. A. Completely 
filled with blood, leaving no air inside the tube (the “No air” samples). B. Partly 
filled with blood leaving ambient air between blood sample and tube cap (the 
“Baseline” and “Ambient air” samples). C. Partly filled with blood followed by 
air bubbling, creating a blood-bubble mixture (the “Air bubbles” samples). 
Table 1 
The increase in seven complement activation products in lepirudin antic-
oagulated blood incubated with either no air, ambient air or air bubbles for 
180 min.      
Complement activation producta Fold increase from baseline 
No air Ambient air Air bubbles  
C4d 0.8 1.1 1.6 
C4bc 2.0 3.0 5.0 
C3a 19 42 57 
C3bc 7.4 16 24 
C3bBbP 13 40 59 
C5a 1.7 7.2 5.0 
TCC 12 26 27 
a C4d, C4bc and C3bBbP n = 6. C3a, C5a and TCC n = 12.  
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Fig. 2. Lepirudin anticoagulated human whole-blood from 12 donors incubated at 37 °C on a roller mixer in tubes with either no air, ambient air, or a mixture of air 
bubbles and blood. After 180 min the blood was analyzed for C4d (A), C4bc (B), C3a (C), C3bc (D), C3bBbP (E), C5a (F) and TCC (G). C4d, C3bc and C3bBbP were 
analyzed in six donors only. Individual readouts are shown as dots with horizontal line at mean. p-values were calculated on log-transformed data using repeated 
measures ANOVA with Geisser-Greenhouse correction and Fischer's LSD test. 
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(1.8–27)) ng/mL (p = 0.003), TCC 4.6 (2.8–6.3) vs. 9.9 (7.3–12) CAU/ 
mL (p = 0.006) (Fig. 2). Readouts from the individual donors are 
shown in supplement 1. 
Seven of the 66 baseline readouts and one readout from the “No air” 
incubations were below lower detection limit and substituted with a 
random number between zero and the lowest detection limit. Due to 
limited amount of plasma, eight baseline readouts were substituted 
with a random number between the lowest and the highest baseline 
value in the series. 
Blood incubated with air bubbles showed an average 26 fold in-
crease from baseline (range 1.6–59) of all complement activation pro-
ducts. For C4d, C4bc, C3a, C3bc and C3bBbP the increase was higher 
than for blood incubated with ambient air only. For C5a and TCC there 
was no difference between incubation with bubbles or ambient air only 
(Table 1 and Fig. 2). 
4. Discussion and conclusion 
We have shown that removing ambient air from test tubes mini-
mized background complement activation in incubated human whole- 
blood. We regard this as a substantial improvement of the original 
whole-blood model (Mollnes et al. 2002), as the very low background 
activation increases the sensitivity of the model, thus enabling us to 
decipher the complex inflammatory interplay in even greater detail. 
Notably, the effect of removing ambient air from the tubes was most 
pronounced for the activation of C3 and less pronounced for the acti-
vation of the C5-9 pathway. This is consistent with the previous find-
ings that the alternative pathway and C3 is the main activating pathway 
at the surfaces between air and plasma (Ekdahl et al. 1992). 
In line with this, we found that blood incubated with air bubbles 
had a higher complement C3 activation than blood incubated with 
ambient air only. However, the increases in C3 activation products 
observed in samples incubated with ambient air amounted to ap-
proximately 70% of the levels observed in samples incubated with air 
bubbles (Fig. 2). This difference in activation could be explained by a 
larger activating blood-air interface on the bubbles. However, we 
cannot exclude that other contributing factors, such as mechanical in-
teraction of bubbles with the blood during roller mixer incubation 
could have contributed to the activation. 
Our findings are highly relevant for most in vitro experiments using 
the whole-blood model, since unwanted background activation of 
complement by ambient air, which is normally present in experimental 
setups, may mask subtle but relevant biological findings. Hence, we 
suggest that in vitro blood experiments should preferably be conducted 
in completely air-free test tubes and the blood's exposure to ambient air 
should be minimized. 
In order to work in the whole-blood model described, we collected 
blood in custom prepared lepirudin filled vacuum tubes. As a possible 
alternative, hirudin filled tubes (S-Monovette 1.6 mL Hirudin, Sarstedt, 
Nümbrecht, Germany) are commercially available. 
It is possible that removal of ambient air from in vitro serum, 
plasma and whole-blood models also could reduce background activa-
tion when studying other biological systems, such as coagulation, cy-
tokines and cell activation. Thus, we recommend that the effect of 
avoiding ambient air in other in vitro models on biological systems is 
elucidated further. 
For clinical diagnostic purposes we suggest neither the use of our 
experimental whole-blood model nor the avoidance of ambient air in 
tubes for these purposes. 
A major practical obstacle towards air-free sample handling is the 
lack of suitable test tubes. To our knowledge, no ordinary test tubes on 
the market are designed for this purpose. At present, avoiding air 
during sample handling is difficult, unhygienic due to difficulties filling 
tubes and tube caps completely, and potentially hazardous due to un-
avoidable blood spills during handling. Thus, new test tubes, as sug-
gested in Fig. 3, needs to be designed to address this problem. 
In conclusion, avoiding ambient air in test tubes during human 
whole-blood in vitro experiments reduce background complement ac-
tivation substantially. 
Supplementary data to this article can be found online at https:// 
doi.org/10.1016/j.jim.2020.112876. 
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